Mirae Asset Global Investments
CRBP icon

Mirae Asset Global Investments’s Corbus Pharmaceuticals CRBP Stock Holding History

Mirae Asset Global Investments’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,880
Closed -$976K – 1745
2024
Q1 		$976K Buy
+24,880
New +$614K ﹤0.01% 1552
2022
Q4 		– Sell
-13,298
Closed -$66K – 2542
2022
Q3 		$66K Sell
13,298
-121,008
-90% -$853K ﹤0.01% 2555
2022
Q2 		$1.02M Buy
134,306
+9,141
+7% +$88.3K ﹤0.01% 1394
2022
Q1 		$2M Sell
125,165
-10,502
-8% -$139K ﹤0.01% 1155
2021
Q4 		$2.51M Buy
135,667
+2,326
+2% +$63K 0.01% 1064
2021
Q3 		$4.08M Sell
133,341
-29,645
-18% -$1.17M 0.01% 911
2021
Q2 		$8.95M Buy
162,986
+49,773
+44% +$2.76M 0.03% 676
2021
Q1 		$6.69M Buy
113,213
+44,876
+66% +$2.95M 0.02% 663
2020
Q4 		$2.56M Buy
68,337
+39,017
+133% +$1.46M 0.01% 841
2020
Q3 		$1.58M Buy
29,320
+4,777
+19% +$865K 0.01% 838
2020
Q2 		$6.18M Buy
24,543
+2,329
+10% +$471K 0.04% 449
2020
Q1 		$3.49M Buy
22,214
+336
+2% +$56.8K 0.03% 511
2019
Q4 		$3.58M Sell
21,878
-15,682
-42% -$2.32M 0.02% 588
2019
Q3 		$5.49M Buy
37,560
+1,721
+5% +$300K 0.04% 447
2019
Q2 		$7.45M Buy
+35,839
New +$7.67M 0.05% 374

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mirae Asset Global Investments's CRBP Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Corbus Pharmaceuticals (CRBP) in Q2 2024, closing a stake of 24,880 shares — an estimated $976K sold.

Mirae Asset Global Investments first reported a position in CRBP in Q2 2019 and held it in 15 quarters. The position peaked at $8.95M in Q2 2021. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Corbus Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 24,880 Corbus Pharmaceuticals shares in Q2 2024, an estimated $976K.
  • Mirae Asset Global Investments first reported a position in Corbus Pharmaceuticals in Q2 2019 and held it in 15 quarters.
  • Mirae Asset Global Investments's Corbus Pharmaceuticals position peaked at $8.95M in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.